Clovis Oncology Inc (NASDAQ:CLVS)

12.10
Delayed Data
As of Dec 10
 +1.39 / +12.98%
Today’s Change
2.93
Today|||52-Week Range
32.05
-32.63%
Year-to-Date
Is Clovis Oncology Really a Buyout Candidate?
Dec 03 / MotleyFool.com - Paid Partner Content
3 Top Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.71
Today’s open11.00
Day’s range10.80 - 12.60
Volume17,918,909
Average volume (3 months)7,841,208
Market cap$527.3M
Data as of 4:00pm ET, 12/10/2019

Growth & Valuation

Earnings growth (last year)+3.97%
Earnings growth (this year)-2.06%
Earnings growth (next 5 years)+32.06%
Revenue growth (last year)+71.84%
P/E ratioNM
Price/Sales9.80
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
ACIUAC Immune SA-0.31-3.58%
GNFTGenfit SA+0.58+3.76%
BDSIBioDelivery Sciences...+0.06+0.94%
CYTKCytokinetics Inc-0.14-1.45%
Data as of 4:00pm ET, 12/10/2019

Financials

Next reporting dateFebruary 25, 2020
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$95.4M
Annual profit (last year)-$368.0M
Net profit margin-385.80%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Boulder, Colorado

Forecasts